Revolution Medicines, Inc. (RVMD)
144.19
-5.36
(-3.58%)
USD |
NASDAQ |
Jun 10, 16:00
144.53
+0.34
(+0.24%)
After-Hours: 06:35
Revolution Medicines Market Cap : 28.86B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 28.86B |
| June 09, 2026 | 29.94B |
| June 08, 2026 | 29.72B |
| June 05, 2026 | 29.87B |
| June 04, 2026 | 31.17B |
| June 03, 2026 | 31.23B |
| June 02, 2026 | 30.29B |
| June 01, 2026 | 32.77B |
| May 29, 2026 | 31.52B |
| May 28, 2026 | 30.95B |
| May 27, 2026 | 32.53B |
| May 26, 2026 | 32.93B |
| May 22, 2026 | 32.22B |
| May 21, 2026 | 32.68B |
| May 20, 2026 | 31.96B |
| May 19, 2026 | 31.32B |
| May 18, 2026 | 30.69B |
| May 15, 2026 | 30.97B |
| May 14, 2026 | 31.78B |
| May 13, 2026 | 31.88B |
| May 12, 2026 | 30.98B |
| May 11, 2026 | 30.65B |
| May 08, 2026 | 30.15B |
| May 07, 2026 | 30.30B |
| May 06, 2026 | 32.12B |
| Date | Value |
|---|---|
| May 05, 2026 | 31.30B |
| May 04, 2026 | 31.44B |
| May 01, 2026 | 27.64B |
| April 30, 2026 | 28.56B |
| April 29, 2026 | 27.85B |
| April 28, 2026 | 28.70B |
| April 27, 2026 | 26.09B |
| April 24, 2026 | 26.81B |
| April 23, 2026 | 26.65B |
| April 22, 2026 | 28.04B |
| April 21, 2026 | 29.51B |
| April 20, 2026 | 28.98B |
| April 17, 2026 | 29.45B |
| April 16, 2026 | 29.58B |
| April 15, 2026 | 30.23B |
| April 14, 2026 | 29.13B |
| April 13, 2026 | 27.01B |
| April 10, 2026 | 19.11B |
| April 09, 2026 | 19.07B |
| April 08, 2026 | 19.17B |
| April 07, 2026 | 19.08B |
| April 06, 2026 | 18.90B |
| April 02, 2026 | 19.64B |
| April 01, 2026 | 19.55B |
| March 31, 2026 | 19.27B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Erasca, Inc. | 4.155B |
| Tango Therapeutics, Inc. | 4.135B |
| Kymera Therapeutics, Inc. | 6.429B |
| Replimune Group, Inc. | 674.48M |
| Arrowhead Pharmaceuticals, Inc. | 9.943B |
Market Cap Related Metrics
| PEG Ratio | -0.265 |
| Price to Book Value | 19.24 |
| Price | 144.19 |
| Earnings Yield | -4.91% |
| PEGY Ratio | -0.265 |